Osimertinib

ATC L01EB04 · 12 markets · 31 records

Osimertinib 12 markets · 31 records Forms

CN 8 records · 2 strengths

80 mgtablet泰瑞沙奥希替尼 also in US·GB·CA +4
40 mgtablet泰瑞沙奥希替尼 also in US·GB·CA +3

US 4 records · 2 strengths

80 mgtabletTAGRISSO also in CN·GB·CA +4
40 mgtabletTAGRISSO also in CN·GB·CA +3

GB 4 records · 2 strengths

80 mgtabletTAGRISSO also in CN·US·CA +4
40 mgtabletTAGRISSO also in CN·US·CA +3

CA 2 records · 2 strengths

80 mgtabletTAGRISSO also in CN·US·GB +4
40 mgtabletTAGRISSO also in CN·US·GB +3

AU 2 records · 2 strengths

80 mgtabletTAGRISSO also in CN·US·GB +4
40 mgtabletTAGRISSO also in CN·US·GB +3

SG 2 records · 2 strengths

80 mgtabletTAGRISSO also in CN·US·GB +4
40 mgtabletTAGRISSO also in CN·US·GB +3

ES 2 records · 2 strengths

80 mgtabletTAGRISSO also in CN·US·GB +4
40 mgtabletTAGRISSO also in CN·US·GB +3

HK 2 records · 1 strengths

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TAGRISSO ×16

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 2 records · 2 strengths

95.4 mgtabletTAGRISSO 40 mg, comprimé pelliculé
47.7 mgtabletTAGRISSO 40 mg, comprimé pelliculé

TW 1 records · 1 strengths

80 mgtabletTAGRISSO+1泰格莎膜衣錠80毫克 also in CN·US·GB +4

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TAGRISSO ×8

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU	FR
80 mg tablet	TAGRISSO	TAGRISSO	TAGRISSO	TAGRISSO	TAGRISSO	泰瑞沙奥希替尼	TAGRISSO	TAGRISSO 泰格莎膜衣錠80毫克	not recorded	not recorded	not recorded
40 mg tablet	TAGRISSO	TAGRISSO	TAGRISSO	TAGRISSO	TAGRISSO	泰瑞沙奥希替尼	TAGRISSO	not recorded	not recorded	not recorded	not recorded
95.4 mg tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAGRISSO 40 mg, comprimé pelliculé
47.7 mg tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAGRISSO 40 mg, comprimé pelliculé
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TAGRISSO	TAGRISSO	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in HK · EU · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en HK · EU · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 HK · EU · FR 有记录（未在本表显示）。另有 3 個規格/劑型僅在 HK · EU · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.